Article

Adele Croteau Discusses the Impact of Her Mother's Cancer

Author(s):

Adele Croteau

We sat down with Adele Croteau, a survivor of cervical cancer from Ottawa, Canada, at I Had Cancer's "A Celebration of Shared Experiences Honoring You."

We sat down with Adele Croteau, a survivor of cervical cancer from Ottawa, Canada, at I Had Cancer's "A Celebration of Shared Experiences Honoring You." In 2008, Adele's mother passed away from ovarian cancer. In 2013, Adele was diagnosed with cervical cancer by the same doctor.

"I took comfort in knowing that I had the same care that she had," Adele says. "She had positive experiences from her care."

Related Videos
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with brown and grey hair.
Image of man with grey hair.
Image of bald man in suit.
Related Content
Image of man with brown hair.
January 11th 2025

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval

Ryan Scott
Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of woman with grey hair.
January 9th 2025

A New Year, A New Approach to Survivorship After Cancer

Felicia Mitchell
As I shift from an oncologist to a gynecologist for breast screenings, I examine both my reluctance to let go of the past and my hopes for the future.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Bonnie Annis shares how she embraces change following a breast cancer diagnosis.
January 3rd 2025

Embracing Change in the Face of Aging and Breast Cancer

Bonnie Annis
I've learned to embrace the changing nature of my body as I age, accepting the challenges and finding gratitude in each day.
The FDA has accepted an NDA for avutometinib and defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer.
January 2nd 2025

FDA Accepts NDA for Avutometinib Plus Defactinib in KRAS+ Low-Grade Serous Ovarian Cancer

Ryan Scott
An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer.